Detection rate of causal variants in severe childhood epilepsy is highest in patients with seizure onset within the first four weeks of life
Open Access
- 2 May 2018
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 13 (1) , 1-8
Abstract
Epilepsy is a heterogeneous disease with a broad phenotypic spectrum and diverse genotypes. A significant proportion of epilepsies has a genetic aetiology. In our study, a custom designed gene panel with 112 genes known to be associated with epilepsies was used. In total, one hundred and fifty-one patients were tested (86 males / 65 females). In our cohort, the highest probability for the identification of the cause of the disease was for patients with a seizure onset within the first four weeks of life (61.9% clarification rate) – about two times more than other groups. The level of statistical significance was determined using a chi-square analysis. From 112 genes included in the panel, suspicious and rare variants were found in 53 genes (47.3%). Among the 151 probands included in the study we identified pathogenic variants in 39 patients (25.8%), likely pathogenic variants in three patients (2%), variants of uncertain significance in 40 patients (26.5%) and likely benign variants in 69 patients (45.7%). Our report shows the utility of diagnostic genetic testing of severe childhood epilepsies in a large cohort of patients with a diagnostic rate of 25.8%. A gene panel can be considered as a method of choice for the detection of pathogenic variants within patients with unknown origin of early onset severe epilepsy.Keywords
Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky (AZV 15-33041)
This publication has 12 references indexed in Scilit:
- Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsyGenetics in Medicine, 2016
- ClinVar: public archive of interpretations of clinically relevant variantsNucleic Acids Research, 2015
- Diagnostic yield of genetic testing in epileptic encephalopathy in childhoodEpilepsia, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Epileptic Encephalopathies: New Genes and New PathwaysNeurotherapeutics, 2014
- The hidden genetics of epilepsy—a clinically important new paradigmNature Reviews Neurology, 2014
- MutationTaster2: mutation prediction for the deep-sequencing ageNature Methods, 2014
- A robust model for read count data in exome sequencing experiments and implications for copy number variant callingBioinformatics, 2012
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNature Protocols, 2009